(Q80828762)
Statements
Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer (English)
Abhik Bandyopadhyay
Long Wang
Fernando López-Casillas
Valentín Mendoza
I-Tien Yeh